POLYPOSIS SYNDROME, HEREDITARY MIXED, 1
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1
|
0.610 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Malignant tumor of colon
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of prostate
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Refractory anemias
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hematochezia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Intussusception
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Rectal polyp
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fibromatosis, Aggressive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adenocarcinoma of duodenum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adenocarcinoma of colon
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Endometrial Carcinoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Polyp of large intestine
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adenomatous colonic polyposis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Juvenile colonic polyposis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperplastic colonic polyposis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Polycystic Ovary Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
<b>Conclusion:</b> Our data suggest that Gremlin 1 may be the key regulator in the pathogenesis of PCOS.
|
30712421 |
2019 |
Chromosome 15q, trisomy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Duplication 15q syndrome (Dup15q) is an autism-associated disorder co-incident with high rates of pediatric epilepsy.
|
28888970 |
2017 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
GREM1 region iii methylation was associated with increased tumor size (P = 0.02), stage (P = 0.013), grade (P = 0.04), tumor (P = 0.001), and endothelial cell (P = 0.0001) proliferation and decreased mean vessel density (P = 0.001) in a hospital-based ccRCC series (n = 150).
|
20042676 |
2010 |
Neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
GREM1, a member of the differential screening-selected gene aberrative in neuroblastoma (DAN) family of genes known for its highly regulated expression pattern during folliculogenesis and a downstream effecter of oocyte-derived growth and differentiation factor 9, was down-regulated 3-fold (-3.08) in women with DOR versus control; down-regulation was confirmed by qRT-PCR (-4.02).
|
22160428 |
2012 |
Central neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
GREM1, a member of the differential screening-selected gene aberrative in neuroblastoma (DAN) family of genes known for its highly regulated expression pattern during folliculogenesis and a downstream effecter of oocyte-derived growth and differentiation factor 9, was down-regulated 3-fold (-3.08) in women with DOR versus control; down-regulation was confirmed by qRT-PCR (-4.02).
|
22160428 |
2012 |
Childhood Neuroblastoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
GREM1, a member of the differential screening-selected gene aberrative in neuroblastoma (DAN) family of genes known for its highly regulated expression pattern during folliculogenesis and a downstream effecter of oocyte-derived growth and differentiation factor 9, was down-regulated 3-fold (-3.08) in women with DOR versus control; down-regulation was confirmed by qRT-PCR (-4.02).
|
22160428 |
2012 |
Diminished ovarian reserve
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GREM1, a member of the differential screening-selected gene aberrative in neuroblastoma (DAN) family of genes known for its highly regulated expression pattern during folliculogenesis and a downstream effecter of oocyte-derived growth and differentiation factor 9, was down-regulated 3-fold (-3.08) in women with DOR versus control; down-regulation was confirmed by qRT-PCR (-4.02).
|
22160428 |
2012 |
Degenerative polyarthritis
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
GREM1, FRZB and DKK1 mRNA expression were strongly decreased in osteoarthritis.
|
24286177 |
2013 |